- Home
- GCTK vs AEMD Comparison
GCTK vs AEMD Comparison
Compare GCTK & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GCTK | AEMD |
|---|---|---|
| Founded | 2001 | 1984 |
| Country | United States | United States |
| Employees | 15 | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3M | 3.6M |
| IPO Year | 2011 | 2008 |
Fundamental Metrics
Financial Performance| Metric | GCTK | AEMD |
|---|---|---|
| Price | $0.86 | $2.20 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.6M | 22.6K |
| Earning Date | 05-13-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 31.22 | N/A |
| Revenue | ★ $589,462.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.02 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.09 | $0.31 |
| 52 Week High | $15.90 | $5.89 |
Technical Indicators
Market Signals| Indicator | GCTK | AEMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 54.95 |
| Support Level | $0.62 | $2.22 |
| Resistance Level | $1.67 | $2.44 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 23.93 | 54.66 |
Price Performance
Historical ComparisonAbout GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.